share_log

領航醫藥生物科技:與建議出售精優藥業控股有限公司(股份代號: 858)約19.14% 已發行股本及 精優藥業控股有限公司所發行 合共577,170,000 港元之可換股債券 有關之非常重大出售事項及關連交易之完成

INNOVATIVE PHAR: COMPLETION OF VERY SUBSTANTIAL DISPOSAL AND CONNECTED TRANSACTION IN RELATION TO PROPOSED DISPOSAL OF APPROXIMATELY 19.14% OF THE ISSUED SHARE CAPITAL OF AND AN AGGREGATE OF HK$577,170,000 CONVERTIBLE BONDS ISSUED BY EXTRAWELL PHARMACEUTI

Oct 8, 2019 10:28
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more